Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Nicox Announces First Patient in China screened in the ongoing NCX 470 Denali Phase 3 Trial in Glaucoma

December 16, 2021

View Press Release Corporate presentation Contact us
Previous